The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enhancing recurrence detection in stage III colorectal cancer patients through molecular residual disease test-guided surveillance: A modeling study.
 
Sumeyye Samur
Consulting or Advisory Role - Exact Sciences
 
Emir Gursel
No Relationships to Disclose
 
Ning Gu
No Relationships to Disclose
 
Gebra Cuyun Carter
Employment - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
 
Mert Sahinkoc
No Relationships to Disclose
 
Turgay Ayer
No Relationships to Disclose
 
Jagpreet Chhatwal
Stock and Other Ownership Interests - crispr therapeutics; Editas Medicine; Intellia Therapeutics
Consulting or Advisory Role - Novo Nordisk
Other Relationship - Value Analytics Labs
 
Rod Tavallai
No Relationships to Disclose
 
Somasundaram Subramaniam
Employment - Exact Sciences
 
Melanie Palomares
Employment - Exact Sciences
Leadership - Cancer Prevention Movement
Stock and Other Ownership Interests - Exact Sciences; LabCorp
Travel, Accommodations, Expenses - Exact Sciences
 
Aparna Parikh
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Checkmate Pharmaceuticals; CVS; Delcath Systems; Foundation Medicine; Guardant Health; Illumina; KAHR Medical; Pfizer; Pfizer; PMV Pharma (I); SAGA Diagnostics; Scarce; Seagen; Sirtex Medical; Taiho Oncology; Takeda; Takeda; UpToDate; Value Analytics Labs; Xilio Therapeutics
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Erasca, Inc; Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); PMV Pharma; PureTech (Inst); Syndax
Travel, Accommodations, Expenses - Karkinos Healthcare; Karkinos Healthcare
Other Relationship - C2i genomics; CADEX Genomics; Parithera; Xact Robotics
 
Rick Baehner
No Relationships to Disclose
 
Alfred Neugut
Stock and Other Ownership Interests - Stemline Therapeutics
Consulting or Advisory Role - Otsuka; United Biosource Corporation; Value Analytics Labs
Research Funding - Kyowa Kirin; Otsuka (Inst)
Expert Testimony - Merck